Embecta (EMBC) Stock Price

Embecta Price

🇺🇸NASDAQ·CLOSED
3.10USD
Market closed
Today +/-
Today %

Embecta (EMBC) Stock | ISIN US29082K1051 | WKN A3DGNE. The current Embecta stock price is 3.1 USD (2026). Revenue is 1.09 B USD. Net income is 170.04 M USD. The P/E ratio is 1.07. Market capitalization is 183.68 M USD. Embecta operates in the Health sector.

Revenue at Embecta has contracted by 0.4% per year over the past 6 years to 1.08 B USD. Earnings per share have declined at 22.5% per year over the last 6 years. For Embecta, the net margin of 8.8% is down versus 35.6% a few years ago. At today's price the dividend yield works out to roughly 19.34%. The payout ratio is around 8% of earnings. The dividend has grown at 26% per year over the past 3 years.

Embecta stock price

Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Embecta over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Embecta stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Embecta's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Embecta Stock Price History
DateEmbecta Price
Access this data via the Eulerpool API

Embecta Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
1.11 B USD
502 M USD
432 M USD
Jan 1, 2020
1.09 B USD
487 M USD
428 M USD
Jan 1, 2021
1.17 B USD
492 M USD
415 M USD
Jan 1, 2022
1.13 B USD
410.8 M USD
223.6 M USD
Jan 1, 2023
1.12 B USD
224 M USD
70.4 M USD
Jan 1, 2024
1.12 B USD
285 M USD
78.3 M USD
Jan 1, 2025
1.08 B USD
329.3 M USD
95.4 M USD
Invalid Date
1.09 B USD
316.9 M USD
170.04 M USD
Invalid Date
1.09 B USD
318.21 M USD
173.96 M USD
Invalid Date
1.1 B USD
321.57 M USD
180.01 M USD
Invalid Date
1.18 B USD
364.14 M USD
0 USD

Embecta Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 19, 2026, 10:19 AM
 
REVENUE (B USD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M USD)
NET INCOME (M USD)
NET INCOME GROWTH (%)
DIV. (USD)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
20222023202420252026e2027e2028e2029e
1.131.121.121.081.091.091.11.18
-3.09-0.80.27-3.831.110.647.01
68.5666.8865.4563.863.163.162.6958.59
774749735689689689689689
223707895170173180-
-46.27-68.6111.4321.7978.951.764.05
0.60.60.60.60.60.230.23-
-61.67
57.557.858.3358.9258.9258.9258.9258.92
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Embecta generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Embecta retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Embecta's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Embecta has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Embecta's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Embecta stock margins

The Embecta margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Embecta. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Embecta.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
70.87 %
45.27 %
38.95 %
Jan 1, 2020
70.26 %
44.84 %
39.41 %
Jan 1, 2021
68.67 %
42.23 %
35.62 %
Jan 1, 2022
68.61 %
36.37 %
19.8 %
Jan 1, 2023
66.91 %
19.99 %
6.28 %
Jan 1, 2024
65.46 %
25.38 %
6.97 %
Jan 1, 2025
63.86 %
30.48 %
8.83 %
Invalid Date
63.86 %
28.99 %
15.56 %
Invalid Date
63.86 %
29.14 %
15.93 %
Invalid Date
63.86 %
29.26 %
16.38 %

Embecta Stock Revenue, EBIT, Earnings per Share

The Embecta earnings per share therefore indicates how much revenue Embecta has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
19.15 USD
8.67 USD
7.46 USD
Jan 1, 2020
18.76 USD
8.41 USD
7.39 USD
Jan 1, 2021
20.12 USD
8.5 USD
7.17 USD
Jan 1, 2022
19.64 USD
7.14 USD
3.89 USD
Jan 1, 2023
19.39 USD
3.88 USD
1.22 USD
Jan 1, 2024
19.26 USD
4.89 USD
1.34 USD
Jan 1, 2025
18.34 USD
5.59 USD
1.62 USD
Invalid Date
18.46 USD
5.38 USD
2.87 USD
Invalid Date
18.44 USD
5.4 USD
2.94 USD
Invalid Date
18.56 USD
5.46 USD
3.04 USD

Embecta business model & stock analysis

Embecta Corp. engages in manufacturing and distributing medical devices used in the treatment of diabetes. The company is headquartered in Parsippany, New Jersey and currently employs 2,200 full-time employees. The company went IPO on 2022-03-21. The firm is focused on providing solutions to people living with diabetes. The firm has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The firm also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. The company distributes its products through a variety of channels, including retail, hospitals, pharmacies and other institutional channels.

Embecta Segments

Embecta Revenue by Segment

  • Max

Pen Needles
Safety
Syringes
Contract Manufacturing
Other
Details
Date
Pen Needles
Safety
Syringes
Contract Manufacturing
Other
Jan 1, 2024
844.4 M USD
129.4 M USD
126.2 M USD
12.8 M USD
4.1 M USD
Jan 1, 2025
784.1 M USD
137.8 M USD
124.6 M USD
19.9 M USD
14 M USD

Embecta Revenue by Region

  • 3 Years

  • Max

United States
International
Details
Date
United States
International
Jan 1, 2022
600.3 M USD
529.2 M USD
Jan 1, 2023
601.4 M USD
519.4 M USD
Jan 1, 2024
607.2 M USD
515.9 M USD
Jan 1, 2025
579.1 M USD
501.3 M USD

Embecta Eulerpool Fair Value

Embecta historical P/E ratio, EBIT multiple, and P/S ratio

Embecta annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Embecta shares outstanding

The number of shares was Embecta in 2025 — This indicates how many shares 58.915 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
57.9 M base_Shares
Jan 1, 2020
57.9 M base_Shares
Jan 1, 2021
57.9 M base_Shares
Jan 1, 2022
57.5 M base_Shares
Jan 1, 2023
57.8 M base_Shares
Jan 1, 2024
58.33 M base_Shares
Jan 1, 2025
58.92 M base_Shares
Invalid Date
58.92 M base_Shares
Invalid Date
58.92 M base_Shares
Invalid Date
58.92 M base_Shares

Embecta Dividend History

5 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.15USDYTD
Feb 27, 20260.15USD 0.0%1/1
20250.6USD 0.0%
Feb 28, 20250.15USD 0.0%1/4
May 28, 20250.15USD 0.0%2/4
Aug 29, 20250.15USD 0.0%3/4
Dec 5, 20250.15USD 0.0%4/4
20240.6USD 0.0%
20230.6USD 100.0%
20220.3USD

Embecta dividend history and estimates

In 2025, Embecta paid a dividend amounting to 0.6 USD. Dividend means that Embecta distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Invalid Date
0.3 USD
0.3 USD
Jan 1, 2023
0.6 USD
0 USD
Jan 1, 2024
0.6 USD
0 USD
Jan 1, 2025
0.6 USD
0 USD
Invalid Date
0.15 USD
0.45 USD
Invalid Date
0 USD
0.23 USD
Invalid Date
0 USD
0.23 USD

Embecta dividend payout ratio

In 2025, Embecta had a payout ratio of 7.71%. The payout ratio indicates the percentage of the company's profits that Embecta distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2019
7.71 %
Jan 1, 2020
7.71 %
Jan 1, 2021
7.71 %
Jan 1, 2022
7.71 %
Jan 1, 2023
7.71 %
Jan 1, 2024
7.71 %
Jan 1, 2025
7.71 %
Invalid Date
7.71 %
Invalid Date
7.71 %
Invalid Date
7.71 %
Price targets and forecasts for Embecta are not yet available.

Embecta Earnings Estimates

Embecta Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
5/8/20260.43USD240.28 MUSD2026 Q2
5/7/20260.43USD240.28 MUSD2026 Q2
2/6/20260.68USD263.2 MUSD2026 Q1
2/5/20260.68USD263.2 MUSD2026 Q1
2/4/20260.68USD263.2 MUSD2026 Q1
11/25/20250.55USD271 MUSD2025 Q4
8/8/20250.79USD283.79 MUSD2025 Q3
11/26/20240.37USD282.53 MUSD2024 Q4
11/19/20240.37USD282.53 MUSD2024 Q4
5/10/20240.48USD275.36 MUSD2024 Q2

EESG©

Eulerpool ESG Scorecard© for the Embecta stock

67/100
60
Environment
99
Social
44
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Embecta shareholder structure

% Name
13.64976%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
8.31133%
American Century Investment Management, Inc.
American Century Investment Management, Inc.
7.62502%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
5.47992%
River Road Asset Management, LLC
River Road Asset Management, LLC
4.64713%
Deerfield Management Company, L.P.
Deerfield Management Company, L.P.
3.9862%
State Street Investment Management (US)
State Street Investment Management (US)
3.97665%
Jefferies LLC
Jefferies LLC
3.8212%
Yacktman Asset Management LP
Yacktman Asset Management LP
2.64845%
William Blair Investment Management, LLC
William Blair Investment Management, LLC
2.38306%
Geode Capital Management, L.L.C.
Geode Capital Management, L.L.C.
...

Embecta Executives and Management Board

DK

Mr. Devdatt Kurdikar

(57)

Chairman of the Board, President, Chief Executive Officer · since 2022

Compensation9.4 M USD
JE

Mr. Jacob Elguicze

(52)

Chief Financial Officer, Senior Vice President

Compensation3.46 M USD
JM

Mr. Jeffrey Mann

(53)

Senior Vice President, General Counsel, Product Development

Compensation3.01 M USD
SC

Mr. Shaun Curtis

(56)

Senior Vice President - Global Manufacturing, Supply Chain and Quality

Compensation2.07 M USD
JC

Ms. Jean Casner

(67)

Chief Human Resources Officer, Senior Vice President

Compensation1.73 M USD

Frequently asked questions about Embecta

All fundamentals and in-depth analysis of Embecta

Our stock analysis for Embecta Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Embecta Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.